Your browser is no longer supported. Please, upgrade your browser.
Settings
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.02 Insider Own0.20% Shs Outstand70.21M Perf Week14.76%
Market Cap928.18M Forward P/E- EPS next Y-0.16 Insider Trans18.48% Shs Float23.31M Perf Month-6.97%
Income-1.20M PEG- EPS next Q-0.11 Inst Own29.90% Short Float37.10% Perf Quarter19.31%
Sales217.80M P/S4.26 EPS this Y-86.60% Inst Trans-31.76% Short Ratio13.23 Perf Half Y45.59%
Book/sh3.72 P/B3.55 EPS next Y66.70% ROA2.00% Target Price16.40 Perf Year4.75%
Cash/sh2.21 P/C5.98 EPS next 5Y28.00% ROE2.70% 52W Range8.70 - 19.96 Perf YTD43.70%
Dividend- P/FCF46.18 EPS past 5Y16.50% ROI2.40% 52W High-33.76% Beta0.83
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin88.30% 52W Low51.95% ATR0.68
Employees423 Current Ratio3.20 Sales Q/Q-40.40% Oper. Margin0.70% RSI (14)58.69 Volatility6.10% 5.31%
OptionableYes Debt/Eq0.00 EPS Q/Q-394.90% Profit Margin3.30% Rel Volume1.38 Prev Close13.72
ShortableYes LT Debt/Eq0.00 EarningsAug 08 BMO Payout0.00% Avg Volume653.78K Price13.22
Recom2.00 SMA205.04% SMA5010.86% SMA20015.96% Volume900,556 Change-3.64%
May-10-17Downgrade Piper Jaffray Overweight → Neutral
Dec-21-16Reiterated RBC Capital Mkts Outperform $23 → $16
Sep-22-16Reiterated RBC Capital Mkts Outperform $32 → $26
Apr-12-16Reiterated Jefferies Buy $23 → $17
Apr-11-16Reiterated Piper Jaffray Overweight $46 → $28
Feb-24-16Reiterated Jefferies Buy $36 → $23
Feb-01-16Reiterated RBC Capital Mkts Outperform $49 → $44
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Jun-26-17 04:12PM  ETFs with exposure to INSYS Therapeutics, Inc. : June 26, 2017 Capital Cube
Jun-23-17 04:40PM  Pot Stock Winners of the Week Investopedia
Jun-20-17 06:50AM  Insys Therapeutics Hires Four Key Pharmaceutical Industry Veterans for Leadership Positions GlobeNewswire
Jun-19-17 02:17PM  Ex-Insys employee pleads guilty in U.S. opioid drug probe Reuters
Jun-18-17 02:03PM  Could Legalized Marijuana Be Making Big Pharma Nervous? Motley Fool
07:43AM  Is Treating Cancer the Next Great Opportunity for Marijuana Stocks? Motley Fool
Jun-16-17 12:03PM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
08:00AM  Will SYNDROS Potential Replace SUBSYS Challenges Accesswire
Jun-15-17 02:15PM  ETFs with exposure to INSYS Therapeutics, Inc. : June 15, 2017 Capital Cube
11:24AM  Cannabis Is Todd Hagopian's Top Biotech Sub-Sector Forbes
11:19AM  Opioid Marketing Under Bipartisan Investigation TheStreet.com
Jun-14-17 09:44AM  These 2 Marijuana Stocks Plunged Last Week: Should You Be Buying? Motley Fool
Jun-12-17 09:30AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : June 12, 2017 Capital Cube
Jun-11-17 02:27PM  Opioid Stocks Feel the Pressure of FDA Measures Investopedia
Jun-10-17 03:22PM  Is the FDA a Big Risk to This Company's Marijuana Plans? Motley Fool
Jun-09-17 05:20PM  Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER TheStreet.com
Jun-08-17 03:41PM  This Marijuana Stock Darling Crashed 17% in May Motley Fool
Jun-06-17 12:33PM  Ex-Insys employee to plead guilty to scheme involving opioid drug Reuters
Jun-05-17 01:58PM  Biotech firm Insys Therapeutics shares drop as sales-practice concerns resurface CNBC -8.66%
01:01PM  Is This Beaten-Down Marijuana Stock (Finally) a Buy? Motley Fool
06:50AM  Insys Therapeutics, Inc. Releases Statement on Its Ongoing Mission GlobeNewswire
Jun-04-17 02:04PM  Marijuana Legalization Could Hurt These Marijuana Stocks Motley Fool
Jun-02-17 02:20PM  This Marijuana Stock Skyrocketed 31% in May Motley Fool
01:24PM  Better Know a Marijuana Stock: Zynerba Pharmaceuticals Motley Fool
Jun-01-17 09:44AM  This Is the Only Marijuana Stock to Rocket Higher by a Double-Digit Percentage Last Week Motley Fool
May-31-17 06:50AM  Insys Therapeutics, Inc. to Present at June Conferences GlobeNewswire
May-28-17 11:44AM  A First-of-Its-Kind Recreational Marijuana Bill Was Just Introduced in New Jersey Motley Fool
May-26-17 03:57PM  Alabama 'pill mill' doctor tied to Insys gets 21 years in prison Reuters
May-24-17 06:50AM  Insys Therapeutics, Inc. Announces FDA Final Product Label for Syndros GlobeNewswire
May-22-17 01:01PM  661 Million Reasons to Like These 3 Marijuana Stocks Motley Fool +5.00%
May-21-17 08:33AM  Cannabis' Impact on the Brain in This New Study Should Encourage Marijuana Stock Investors Motley Fool
May-20-17 03:15PM  Marijuana Stock Winners of the Week Investopedia
11:43AM  3 Top Marijuana Stocks That Are Profitable (but There's a Catch) Motley Fool
May-16-17 06:50AM  Insys Therapeutics Announces Chief Financial Officer Transition GlobeNewswire
May-15-17 06:00PM  Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit has been Filed against Insys Therapeutics, Inc. (INSY) and Encourages Investors to Contact the Firm Accesswire
02:12PM  The Klein Law Firm Reminds Investors of the Filing of a Class Action on Behalf of INSYS Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of May 16, 2017 Accesswire
10:22AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) and Lead Plaintiff Deadline - May 16, 2017 Accesswire
May-14-17 03:10PM  Edited Transcript of INSY earnings conference call or presentation 9-May-17 2:00pm GMT Thomson Reuters StreetEvents
May-13-17 02:03PM  What You Need to Know About Marijuana Stocks Motley Fool
May-12-17 06:20PM  The Wagner Firm Reminds Investors of May 16th Deadline in the Class Action Lawsuit Against Insys Therapeutics, Inc. Business Wire
08:30AM  UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of INSYS Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 16, 2017 - INSY Accesswire
May-11-17 06:58PM  INSYS Therapeutics, Inc. Value Analysis (NASDAQ:INSY) : May 11, 2017 Capital Cube
11:44AM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Insys Therapeutics, Inc. - INSY PR Newswire
10:30AM  May 16 Deadline Alert: Tostrud Law Group, P.C. Reminds Investors of Upcoming Deadline in the Class Action Lawsuit Against Insys Therapeutics, Inc. Business Wire
09:17AM  3 Top Biotech Stocks For May Motley Fool
09:10AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. Accesswire
May-10-17 05:01PM  Here's Why Marijuana Stock Insys Therapeutics Briefly Plunged As Much As 11% Motley Fool
04:52PM  INSY Investors: GPM Reminds Investors of the May 16 Deadline in the Class Action Lawsuit Against Insys Therapeutics, Inc. Business Wire
04:21PM  Investors Are Betting Big Against Marijuana Stock Insys Therapeutics -- Why They're Wrong Motley Fool
02:23PM  INSYS Therapeutics, Inc.: Gathering momentum, can it sustain its performance? Capital Cube
10:10AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) & Lead Plaintiff Deadline - May 16, 2017 GlobeNewswire
08:30AM  Investor Network: Insys Therapeutics, Inc. to Host Earnings Call Accesswire
08:16AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : May 10, 2017 Capital Cube
08:00AM  Today's Research Reports on Stocks to Watch: Insys Therapeutics and Epizyme Accesswire
May-09-17 04:50PM  Why Insys Therapeutics Inc. Jumped Higher Today Motley Fool +10.39%
02:17PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. Business Wire
12:16PM  Insys in talks with U.S. to resolve probe of opioid spray Reuters
11:01AM  Insys Therapeutics Reports First Quarter 2017 Results GlobeNewswire
10:35AM  Insys Therapeutics reports 1Q loss Associated Press
10:30AM  May 16 Deadline Alert: Law Offices of Howard G. Smith Reminds Insys Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Business Wire
09:15AM  Investor Network: Insys Therapeutics, Inc. to Host Earnings Call Accesswire
May-08-17 12:20PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. Accesswire
12:19PM  5 Earnings Short-Squeeze Plays: Snap, NVIDIA & More TheStreet.com
08:06AM  The 3 Most Undervalued Marijuana Stocks (With a Twist) Motley Fool
May-05-17 07:20PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY Accesswire
04:00PM  Why This Marijuana Stock Rallied Higher in April Motley Fool
May-04-17 08:45AM  Insys Therapeutics, Inc. Appoints Rohit Vishnoi to Board of Directors GlobeNewswire
May-02-17 01:06PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders it Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. Accesswire
10:21AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) and Lead Plaintiff Deadline - May 16, 2017 Accesswire
May-01-17 02:59PM  The Klein Law Firm Reminds Investors of the Filing of a Class Action on Behalf of INSYS Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of May 16, 2017 GlobeNewswire
08:32AM  Which Marijuana Stock Will Be Next to Reach a $1 Billion Valuation? Motley Fool
Apr-30-17 09:00AM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline INSY GlobeNewswire
Apr-28-17 11:36AM  INSY INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of INSYS Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 16, 2017 INSY GlobeNewswire
10:20AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) and Lead Plaintiff Deadline - May 16, 2017 Accesswire
Apr-27-17 04:42PM  Rosen Law Firm Reminds Insys Therapeutics, Inc. Investors of Important Deadline Class Action INSY GlobeNewswire
08:34AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : April 27, 2017 Capital Cube
Apr-26-17 12:11PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. GlobeNewswire +6.66%
10:30AM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Insys Therapeutics, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
Apr-25-17 04:30PM  Insys Therapeutics to Report First Quarter 2017 Results on May 9, 2017 GlobeNewswire
Apr-24-17 04:37PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. Accesswire
07:00AM  Dr. Steven James Joins Insys Therapeutics as Vice President of Medical Affairs GlobeNewswire
Apr-21-17 11:08AM  Better Know a Marijuana Stock: Insys Therapeutics Motley Fool
10:20AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) and Lead Plaintiff Deadline: May 16, 2017 Accesswire
Apr-20-17 02:20PM  ETFs with exposure to INSYS Therapeutics, Inc. : April 20, 2017 Capital Cube
Apr-19-17 04:32PM  INSY EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of INSYS Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 16, 2017 - INSY Accesswire
Apr-14-17 06:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY Accesswire
Apr-13-17 03:40PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. Business Wire
10:19AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) and Lead Plaintiff Deadline: May 16, 2017 Accesswire
07:54AM  One company symbolizes everything sickening about the opioid crisis Business Insider
Apr-11-17 09:30AM  Biotech Movers Trading Positive Ahead of Market's Open TheStreet.com
08:15AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : April 11, 2017 Capital Cube
Apr-10-17 11:38AM  The Klein Law Firm Announces the Filing of a Class Action on Behalf of INSYS Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of May 16, 2017 Accesswire +6.47%
08:25AM  5 Drug-Developing Marijuana Stocks You Need to Know Motley Fool
Apr-07-17 08:07PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY Accesswire
04:53PM  ETFs with exposure to INSYS Therapeutics, Inc. : April 7, 2017 Capital Cube
Apr-06-17 03:57PM  The Klein Law Firm Announces a Class Action Filed on Behalf of INSYS Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of May 16, 2017 GlobeNewswire
01:28PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Insys Therapeutics, Inc. INSY GlobeNewswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) & Lead Plaintiff Deadline: May 16, 2017 GlobeNewswire
Apr-05-17 05:00PM  DepoMed, Opioid Makers Fall After Trump's FDA Pick Says America's Drug Addiction Is Out of Control TheStreet.com
12:34PM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017 Capital Cube
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is SYNDROS, an orally administered liquid formulation of dronabinol for treating CINV and anorexia associated with weight loss in patients with AIDS. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Motahari SaeedPresident & CEOJun 14Buy11.105,40059,9559,900Jun 14 03:19 PM
Vishnoi RohitDirectorJun 01Buy14.144,00056,5754,000Jun 02 03:14 PM
FOURTEAU PATRICKDirectorMay 26Option Exercise3.6310,00036,30059,682May 26 04:26 PM
MEYER STEVEN JDirectorMay 18Buy12.218,00097,68052,083May 18 04:48 PM
Motahari SaeedPresident & CEOMay 16Buy11.984,50053,9324,500May 16 08:53 PM
MEYER STEVEN JDirectorNov 04Buy10.7510,000107,48944,083Nov 07 10:14 AM
MEYER STEVEN JDirectorSep 01Option Exercise13.575006,78534,083Sep 01 04:23 PM
STANLEY THEODORE HDirectorAug 16Option Exercise5.9615,00089,40017,000Aug 16 08:23 PM
STANLEY THEODORE HDirectorAug 16Sale18.0215,000270,3002,000Aug 16 08:23 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerAug 12Buy18.575,700105,85342,430,310Aug 12 03:40 PM
FOURTEAU PATRICKDirectorAug 11Sale18.4615,000276,90049,682Aug 12 04:51 PM
BRENNAN DANIELExec VP & Chf Operations Off.Aug 09Sale19.165,781110,7521Aug 09 07:12 PM
MEYER STEVEN JDirectorAug 04Option Exercise14.081,19416,80633,583Aug 04 06:49 PM
MEYER STEVEN JDirectorJul 06Option Exercise14.4469510,03632,389Jul 06 04:12 PM